In the TOGETHER-PsA trial, Merola and colleagues assessed the efficacy and safety of combination therapy with ixekizumab (Taltz, Eli Lilly) plus tirzepatide (Zepbound, Eli Lilly), compared with ixekizumab alone in a cohort of 271 adults with active PsA and overweight or obesity, aligned with the on-label dosing of both interventions
Suggested Reading Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses
Vitamin B12 deficiency is generally suspected based on related symptoms, clinical findings, and laboratory results and is confirmed by measuring vitamin B12 levels
side effects typically diminish Months 6-12+: Continued weight loss toward plateau
Estrogen-Dependent Cancers
Although prevalence estimates vary according to diagnostic criteria, the global prevalence of SO among adults aged 60 years and older has been reported 11% [3]